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Okazaki fragments contain an initiator RNA/DNA primer
that must be removed before the fragments are joined. In
eukaryotes, the primer region is raised into a flap by the strand
displacement activity of DNApolymerase . TheDna2 helicase/
nuclease and then flap endonuclease 1 (FEN1) are proposed to
act sequentially in flap removal. Dna2 and FEN1 both employ a
tracking mechanism to enter the flap 5 end and move toward
the base for cleavage. In the current model, Dna2 must enter
first, but FEN1 makes the final cut at the flap base, raising the
issue of how FEN1 passes the Dna2. To address this, nuclease-
inactive Dna2 was incubated with a DNA flap substrate and
found to bind with high affinity. FEN1 was then added, and sur-
prisingly, there was little inhibition of FEN1 cleavage activity.
FEN1was later shown, by gel shift analysis, to remove the wild
type Dna2 from the flap. RNA can be cleaved by FEN1 but not
by Dna2. Pre-bound wild type Dna2 was shown to bind an
RNA flap but not inhibit subsequent FEN1 cleavage. These
results indicate that there is a novel interaction between the
two proteins in which FEN1 disengages the Dna2 tracking
mechanism. This interaction is consistent with the idea that
the two proteins have evolved a special ability to cooperate in
Okazaki fragment processing.
Replication of eukaryotic cellularDNA involves the synthesis
and joining of Okazaki fragments on the lagging strand. These
fragments are 100–150 nucleotides long in eukaryotes (1).
They are initiated by polymerase /primase (pol )2 complex,
which synthesizes 10–12 nucleotides of RNA followed by20
nucleotides of DNA (2). pol  is then replaced by a complex
consisting of proliferating cell nuclear antigen and polymerase
 (pol ) through a process known as polymerase switching.
Polymerase  (pol ) may also play a role in lagging strand syn-
thesis or processing, because some portion of the cellular pro-
liferating cell nuclear antigen is bound by pol  during S-phase
(3, 4). DNA synthesis continues until pol  encounters a down-
stream Okazaki fragment, at which time strand displacement
synthesis creates a single-stranded flap (5–7). This flap must
then be processed to form a continuous strand of DNA, a path-
way known as Okazaki fragment processing (OFP).
Several models of OFP have been developed from reconsti-
tution studies in vitro in which nuclease activity is used to
remove the primermade by pol  followed by ligation to form a
continuous strand (6, 8, 9).Onemodel, proposed by theBurgers
group (5, 10), suggests that short flaps are created by pol 
strand displacement synthesis and are successively cleaved by
flap endonuclease 1 (FEN1). Saccharomyces cerevisiae FEN1,
also known as Rad27p, is a 42-kDa protein with 5 to 3 single-
stranded DNA (ssDNA) endonuclease activity and minor 5 to
3 exonuclease activity (11). FEN1 has been shown to cleave at
the base of a 5 single-stranded flap substrate (11–13). Addi-
tionally, FEN1 has been shown to prefer short flaps to long flaps
(5, 14).
S. cerevisiae Dna2 was first implicated in OFP when it was
found to associate both genetically and physically with FEN1
(15). It has recently been shown to be associated with other
components ofOFP, including ExoI, RNaseH2, Rrm3, Sgs1, and
Pol32 (16). Dna2 is a 172-kDa protein that is essential in yeast
(17–20) and has two domains, as determined by limited prote-
olysis studies (21). One domain, found at the C terminus, pos-
sesses ssDNA-dependent ATPase activity and ATP-dependent
5 to 3 helicase activity (17, 22, 23). The second domain,
located between residues 650 and 700, contains homology to
the RecB nuclease domain. This domain contains 5 to 3, and
minor 3 to 5, ssDNA nuclease activities (23, 24). The ratio of
helicase and nuclease activities can be regulated in vitro byATP
concentration (18, 25, 26). Dna2 was further implicated in OFP
when the ssDNA-binding protein, replication protein A (RPA),
was shown to physically interact with Dna2 (27, 28) and stimu-
late Dna2 activity while repressing FEN1 activity on a flap sub-
strate (5, 10, 14, 25, 28, 29). This led to the RPA/Dna2/FEN1
model, proposed by the Seo group (23). In this model, flaps
displaced by pol  reach a length that allows them to be coated
byRPA. BoundRPA inhibits cleavage by FEN1but not byDna2.
Dna2would then cleave these RPA-coated flaps, releasing RPA.
Dna2 does not have cleavage specificity for the flap base (14).
Instead it produces short (5–7 nucleotides), RPA-free flaps that
are substrates for FEN1. The current view is that some portion
of OFP occurs by the RPA/Dna2/FEN1 pathway (9).
The model above suggests that a unique interplay between
Dna2 and FEN1 exists. As stated previously, FEN1 and Dna2
interact physically with each other. The experiments discussed
in this paper are used to further understand the interaction
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between these two proteins. Both FEN1 and Dna2 have been
shown to employ a tracking mechanism to cleave the flap sub-
strate (13, 30, 31). They bothmust interactwith the 5 endof the
flap and thenmove to the site of cleavage.Dna2was found to act
as if it were threaded onto the flap like a bead on a string (30).
Because they are proposed to act in order, theDna2must cleave
but then allow the FEN1 to have access to the 5 end of the
shorter flap. In this study, we used a nuclease-inactive Dna2 to
block the base of a flap substrate and then determined whether
FEN1 could access the substrate. Surprisingly, FEN1 was capa-
ble of efficient cleavage. We then explored the mechanism by
which FEN1 could reach its cleavage site.
EXPERIMENTAL PROCEDURES
Materials—Synthetic oligonucleotides, including the 5-bio-
tin conjugation, were produced by Integrated DNA Technolo-
gies. Radionucleotide [-32P]dCTP (6000 Ci/mmol) was
obtained from PerkinElmer Life Sciences. The Klenow frag-
ment of DNA polymerase I and ATP were from Roche Applied
Science. All other reagents were the best available commercial
grade.
Enzyme Expression and Purification—S. cerevisiae Dna2 was
cloned into the Sf9 baculovirus expression vector (Invitrogen).
It was then expressed and purified as described previously (18),
except that High Five cells were utilized for the final expression
step of the protein. S. cerevisiae Dna2 E675A was created by
site-directed mutagenesis as described in Ref. 18. It was then
expressed and purified as described above for the wild type
Dna2. S. cerevisiae FEN1 was cloned into the T7 expression
vector pET-FCH and overexpressed in Escherichia coli. It was
then purified as described previously (26).
Oligonucleotides—All downstream primers were labeled at
the 3 terminus with [-32P]dCTP (6000 Ci/mmol) by the Kle-
now enzyme. They were then purified on a 12% polyacrylamide
gel containing 7 M urea. DNA substrates were annealed in 50
mM Tris, pH 8.0, 50 mM NaCl, and 1 mM dithiothreitol (DTT),
and substrates containing RNA were annealed in 10 mM Tris,
pH8.0, 1mMEDTA, and 50mMNaCl. For annealing, substrates
were incubated at 95 °C for 5 min and then cooled slowly to
room temperature. Protector RNase Inhibitor (Roche Applied
Science) was then added to RNA-containing substrates. All sub-
strates were annealed in a 1:2:4 ratio of downstream primer to
template to upstream primer. Most experiments described were
done using a 53-nucleotide DNA flap substrate. This substrate
consisted of the following: downstream primer-5-/biotin/GTA-
CCGAGCTCGAATTCGCCCGTTTCACGCCTGTTAGTTA-
ATTCACTGGCCGTCGTTTTACAACGACGTGACTGGG-
3, upstream primer-5-CGCCAGGGTTTTCCCAGTCAC-
GACA-3, and template-5-GCCCAGTCACGTCGTTGT-
AAAACGGGTCGTGACTGGGAAAACCCTGGCG-3. The
experiments shown in Fig. 5 involved a 30-nucleotide RNA flap
substrate, which consisted of the following primers (RNA is in
bold): downstreamprimer-5-GUCACGCCUGUUAGUUAAU-
UCACUGGCCGUCCACCCGUCCACCCGACG-3, upstream
primer-5-CGACCGTGCCAGCCTAAATTTCAAGA-3, and
template-5-GCGTCGGGTGGACGGGTGGCTTGAAATTT-
AGGCTGGCACGGTCG-3.
Nuclease Assay—The reaction buffer for both Dna2 and
FEN1 reactions consisted of 50 mM Tris-HCl, pH 8.0, 30 mM
NaCl, 2 mM DTT, 0.1 mg/ml bovine serum albumin, 2 mM
MgCl2, 5% glycerol, and 10 M ATP. The reaction mixture vol-
ume was 20 l, which included 5 fmol of labeled substrate and
various amounts of enzymes, as indicated in the figure legends.
Reactions were then incubated for 10 min at 37 °C, unless oth-
erwise indicated, and stopped with a 2 termination dye (90%
formamide (v/v), 10 mM EDTA, with 0.01% bromphenol blue
and xylene cyanol). Reactions were then separated on a 15%
polyacrylamide gel containing 7 M urea. Pre-binding Dna2 con-
ditions were as follows. Dna2 and labeled substrate weremixed,
incubated for 10 min on ice, and then incubated for 5 min at
37 °C. In Figs. 1B and 5B, Dna2 was pre-bound prior to FEN1
addition. In Figs. 1B and 3, streptavidin was used in 50-fold
excess over substrate and was conjugated to the 5-biotin by
incubation at 37 °C for 10min. In Fig. 2, 50microunits ofmicro-
coccal nuclease (Fermentas) in 50 mMTris-HCl, pH 8.0, 30 mM
NaCl, 2 mM DTT, 0.1 mg/ml bovine serum albumin, and 2 mM
CaCl2 was added after Dna2 E675A was bound to substrate, as
described previously. The reaction was then incubated at 37 °C
for 10 min. For experiments using RNA, Protector RNase
Inhibitor (Roche Applied Science) was added to help prevent
RNA degradation.
Gel Shift Assay—This assay was used to determine the bind-
ing of Dna2 and/or FEN1 to various labeled substrates. Reac-
tions were performed in 50 mM Tris-HCl, pH 8.0, 30 mMNaCl,
2 mM DTT, 0.1 mg/ml bovine serum albumin, 5% glycerol, 10
M ATP, and either 2 mM MgCl2, with Dna2 E675A, or 4 mM
CaCl2, with wild type Dna2. The reaction mixture volume was
20 l, which included 5 fmol of labeled substrate and various
amounts of enzymes, as indicated in the figure legends. In
Figs. 1A and 5A, various amounts of Dna2 were pre-bound, as
described above. In Fig. 4, Dna2was pre-bound, and then FEN1
was added to the reaction mix at various concentrations and
incubated for 5 min at 37 °C. The 5 terminus of the substrate
was then blocked by the addition of 250 fmol of streptavidin,
which was conjugated to the 5-biotin on the flap. In Fig. 6,
streptavidin (250 fmol) was incubatedwith substrate for 10min
at 37 °C. Dna2 was then added, and reactions were incubated
again at 37 °C for 10min. Reactions were then run on a pre-run
5% (Bio-Rad) or 6% (Invitrogen) Tris borate-EDTA gel at 200 V
for 20–40 min.
Gel Analysis—All experiments were done at least in dupli-
cate, and representative gels are shown. All gels, after running
conditions, were transferred to filter paper and dried on a gel
dryer (Bio-Rad) with vacuum (Savant) for 1 h at 80 °C. They
were then exposed to a Phosphor screen and imaged using a
PhosphorImager (GE Healthcare). Gel analysis was then per-
formed using ImageQuantMac, version 1.2 (GE Healthcare).
RESULTS
Dna2 is expected to precede FEN1 in tracking on a flap dur-
ing OFP. Even after cleavage by Dna2 its helicase activity would
be expected to drive it onto the flap so that it would block the
entry of FEN1. It is known that FEN1 can access the flap after
Dna2 cleavage. We hypothesized that the two proteins are
designed to allow efficient, successive action. To understand
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how Dna2 works with FEN1, we assessed FEN1 binding and
cleavage to a flap already occupied by a Dna2 molecule.
Dna2 E675A Binds Flaps but Does Not Inhibit FEN1—Dna2
E675A was characterized previously and shown to be defective
in nuclease activity while retaining helicase activity (18). We
confirmed both a defect in cleavage activity and retention of
helicase activity of Dna2 E675A on a flap substrate (data not
shown). It was previously shown that Dna2 binds to flap sub-
strates by gel shift assay (28). We tested whether Dna2 E675A
could bind to a flap substrate and block FEN1 cleavage. Because
we have previously shown that FEN1 requires a free 5 end for
tracking to the base of the flap and cleavage (13), we hypothe-
sized that Dna2 E675A binding would inhibit FEN1 cleavage at
the base of the flap. The approach was to load Dna2 so that it
tracks or binds to the base of the flap but does not cleave. We
used an ATP concentration that allows the Dna2 to bind onto
the flap but does notmake the helicase function so potently that
it displaces the flap and dissociates the primer from the tem-
plate (data not shown). Fig. 1A shows native PAGE separation
of the 53-nucleotide flap substrate with Dna2 E675A present.
Upon addition of purified Dna2 E675A (Fig. 1A, lanes 2 and 3),
we saw a gel shift from the position of the DNA only band (Fig.
1A, lane 1) to a higher molecular weight band signifying bind-
ing. The fraction of shifted DNA was dependent on Dna2
E675A concentration. At 200 fmol ofDna2 E675A (Fig. 1A, lane
3), at least 80% of the DNA was bound with protein, as some
portion of the protein may have been dissociated during
electrophoresis.
Dna2 E675Awas then pre-bound, under the same conditions
shown in Fig. 1A, lane 3, to the 53-nucleotide flap substrate.
This should have prevented FEN1 access to at least 80% of the
substratemolecules. FEN1was added to the reactionmixture at
the end of the pre-binding period. When FEN1 was incubated
with the substrate in the absence of
Dna2 E675A (Fig. 1B, circles), an
increasing amount of flaps were
cleaved over time. Upon addition of
FEN1 to pre-bound substrate (Fig.
1B, squares), the flaps were also
cleaved efficiently. Surprisingly, the
presence of the Dna2 E675A made
only a slight difference in the
amount of cleavage, indicating that
the FEN1 had access to its cleavage
site on nearly all of the substrates.
Inhibition of FEN1 cleavage by
Dna2 E675A was compared with
that of a 5 streptavidin-biotin-
blocked flap (Fig. 1B, diamonds).
The almost complete elimination of
cleavage activity verifies that pre-
vention of FEN1 entry to the flap is
an effective deterrent to cleavage.
The early time points can be used
to compare relative rates of cleavage
(Fig. 1B, 0.5 and 1 min). Blockage of
the flaps by Dna2 E675A resulted in
a less than 2-fold decrease in cleav-
age rate (compare Fig. 1B, squares and circles), strikingly less
inhibitory than the effect of streptavidin (Fig. 1B, diamonds).
The difference in rate was reduced to only 4% by 10min, simply
because cleavage goes to near completion even in the presence
of Dna2 E675A.Moreover, cleavage productsmade by FEN1, as
seen on the gel, appeared identical on both unblocked andDna2
E475A-blocked substrates (data not shown). This demonstrates
that FEN1 reached the base of the flap for cleavage at its pre-
ferred site in both cases. Titrations of Dna2 E675A up to 200
fmol were performed in the pre-binding reaction and showed
no significant effect on the amount of FEN1 cleavage (data not
shown). Overall, these results show that FEN1 can bypass Dna2
boundon a flap, thus gaining access to the flap base for cleavage.
Dna2 E675A Should Block FEN1 Access to the Flap—Be-
cause Dna2 appears to thread onto the flap, it is difficult to
visualize how FEN1 could cleave around a bound Dna2 mol-
ecule. We determined whether FEN1 would have access to the
flap during brief absences of Dna2, as might occur if Dna2 pro-
teins occasionally slide off the 5 end of the flap. Dna2 E675A
was bound to the 53-nucleotide labeled DNA flap substrate,
and micrococcal nuclease was then added (Fig. 2). Micrococcal
nuclease is an endonuclease, which, unlike Dna2 or FEN1, has
no loading requirement and can readily cleave exposed DNA.
In addition, it prefers ssDNA over double-stranded DNA. In
Fig. 2, Dna2 E675A was bound prior to micrococcal nuclease
addition. This allowed us to evaluate the percent of substrates
that were inaccessible to micrococcal nuclease and thus pro-
tected by bound Dna2 E675A. Fig. 2, lane 2, shows the amount
of micrococcal nuclease cleavage without Dna2 E675A present.
In contrast, whenDna2 E675Awas bound to the substrate prior
to micrococcal nuclease addition, there was a decrease in the
amount of products formed after a 10-min incubation with
micrococcal nuclease (Fig. 2, lanes 3–5). Upon quantitation of
FIGURE 1. FEN1 cleavage is not inhibited by Dna2 E675A-bound flaps. A, a gel shift assay was preformed
with 100 fmol (lane 2) and 200 fmol (lane 3) of Dna2 E675A and 5 fmol of the 53-nucleotide flap substrate as
indicatedunder “Experimental Procedures.” Lane 1 is the substrate alone control. Percent bound, shownbelow
the gel, is defined as: (bound/(bound  unbound))  100. B, 5 fmol of the 53-nucleotide flap substrate was
incubated under the following conditions (described under “Experimental Procedures”): circles, 5 fmol of FEN1
was added at time zero; squares, 200 fmol of Dna2 E675Awas pre-boundwith substrate prior to FEN1 addition
at time zero; diamonds, 250 fmol of streptavidin was pre-bound with substrate prior to FEN1 addition at time
zero. Time points were taken at 0, 0.25, 0.5, 1, 2.5, 5, and 10 min. Percent cleavage is defined as: (cleaved/
(cleaved  uncleaved))  100. The graph is an average of two experiments, and error bars indicate S.D. The
substrate, used in both A and B, is depicted above the gel in A, where the asterisk indicates the site of the 3 32P
radiolabel and B indicates the 5-biotin.
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the protected area (indicated in Fig. 2), we determined that
Dna2 E675A protected60% of the substrates from cleavage at
the base of the flap when 200 fmol of Dna2 E675A was used.
This corresponds to the concentration of Dna2 E675A used in
Fig. 1B. Similar results were seen with wild type Dna2 (data not
shown). Overall, these results suggest that Dna2 does not tran-
siently leave the flap in a way that allows the flap to become
accessible to FEN1.
FEN1 Tracking Is Not Bypassed by Dna2—We next consid-
ered several hypotheses to explain the ability of FEN1 to bypass
bound Dna2. Because FEN1 and Dna2 interact (15), it is possi-
ble that FEN1 binds to Dna2, bound to the flap, from solution
and can cleave without tracking. We tested this idea by using
the 5 streptavidin-biotin-blocked substrate. Dna2 E675A was
pre-bound to the substrate followed by conjugation with
streptavidin to form the streptavidin-biotin block. FEN1 was
then added. When FEN1 was incubated alone with blocked
substrates that contained no boundDna2 E675A (Fig. 3, lane 3),
there was almost complete suppression of the substantial cleav-
age observed with the unblocked substrate (Fig. 3, lane 7). The
small residual amount of cleavage is most likely because of a
contamination of substrates lacking biotin, suggested by a fail-
ure to bind streptavidin (see Fig. 4, lane 2). In Fig. 3, lanes 4–6,
Dna2 E675Awas pre-bound prior to the flap blockage and sub-
sequent FEN1 addition. We observed no additional cleavage in
these reactions (Fig. 3, lanes 4–6) compared with the reaction
without Dna2 (Fig. 3, lane 3). These data show that FEN1 is
unable to employ Dna2 E675A bound on the flap as a means to
bypass the FEN1 5 end entry and tracking requirements.
FEN1 Accomplishes Direct Removal of Dna2—We next set
out to determine whether FEN1 is able to disengage Dna2 from
the flap, enabling FEN1 to gain access to the base of the flap.
This experiment required FEN1 and Dna2 to bind but not
cleave the substrate. Both FEN1 and Dna2 use Mg2 for nucle-
FIGURE 2. Dna2 blocks micrococcal nuclease cleavage. Dna2 E675A, 100
fmol (lane 3), 200 fmol (lane 4), and 500 fmol (lane 5), was pre-bound to 5 fmol
of the labeled53-nucleotide flap, andmicrococcal nuclease (MNase)was then
added at time zero as described under “Experimental Procedures.” The reac-
tion was then incubated at 37 °C for 10 min. Lane 1 is the substrate alone
control, lane 2 ismicrococcal nucleasewithoutDna2present, and lane 6 is the
highest Dna2 E675A concentration without micrococcal nuclease. In lane 7,
FEN1 was used to identify the base of the flap. Percent protection is defined
as: (area of protection/(area of protection  uncleaved substrates))  100.
The substrate used is depicted above the gel, the asterisk indicates the site of
the 3 32P radiolabel, and B indicates the 5-biotin. FIGURE 3. Bound Dna2 E675A does not allow bypass of FEN1 tracking.
A nuclease assay was used to assess the cleavage of FEN1 on the 53-nucleo-
tide flap as described under “Experimental Procedures.” Streptavidin (lanes
1–6) andDna2 E675A (lanes 2 and 4–6) were preincubatedwith the substrate
as described under “Experimental Procedures.” Dna2 E675A (500 fmol) was
pre-bound to 5 fmol of substrate, which was then blocked with streptavidin.
0.1 (lane 4), 0.5 (lane 5), and 1 fmol (lane 6) of FEN1 was then added. Lane 7
indicates the amount of FEN1 (1 fmol) cleavage without pre-bound strepta-
vidin compared with lane 3 with streptavidin. Lane 1 is substrate alone, and
lane 2 is substrate bound by Dna2 E675A (500 fmol) without FEN1 added.
Percent cleavage, shown below the gel, is defined as: (cleaved/(cleaved 
uncleaved)) 100. The substrate is depicted above the gel, the asterisk indi-
cates the site of the 3 32P radiolabel, and B indicates the 5-biotin.
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ase activity. However, substitution of CaCl2 for MgCl2 was
found to inhibit nuclease activity while still allowing effective
binding of the substrate (31, 32) (see Fig. 4). This also allowed
for the use of wild type Dna2 in this experiment. Binding of
Dna2 and FEN1 to the biotinylated flap substrate was assessed
by gel shift. Streptavidin was used to prevent rebinding and
allow FEN1 to be trapped onto the substrate, because FEN1,
unlike Dna2, appears to equilibrate rapidly between unblocked
substrates (data not shown). In the first set of experiments,
increasing amounts of FEN1 were added to the substrate fol-
lowed by addition of streptavidin (Fig. 4, lanes 3–5). Results
showed that progressively more FEN1 was bound. Dna2 was
then pre-bound followed by the addition of FEN1 and finally
streptavidin (Fig. 4, lanes 7–9); lanes 7–9 show a progressive
increase in binding of FEN1 to the substrate as the concen-
tration of FEN1 was increased. Moreover, there was a pro-
gressive decrease in the density of the band representing
bound Dna2, indicating that it was being removed from the
flap. Although this displacement was not completely quan-
titative, as a minor amount of Dna2 appears to remain bound
(Fig. 4, lane 9), the majority of Dna2 was efficiently removed
from the flap. These results show that the addition of FEN1
to a reaction containing substrate with pre-bound Dna2
caused the removal of Dna2 from the flap. Surprisingly, even
though the Dna2 appeared to thread onto the flap on entry, a
FEN1 molecule following behind it could directly disengage
it from the flap.
Pre-bound Wild Type Dna2 Does Not Inhibit FEN1 Activity—
Itwas also important to demonstrate that the ability of FEN1 to
cleave a flap with boundDna2was not only characteristic of the
Dna2E675Amutant but also of thewild type. Tomeasure FEN1
cleavage with the wild type Dna2, we needed to inhibit Dna2
nuclease function while retaining FEN1 cleavage activity. This
was accomplished by exploiting a key difference in substrate
specificities between the two nucleases, namely the ability of
FEN1, but not Dna2, to cleave an RNA substrate (23, 33). We
created a flap substrate in which the 30-nucleotide flap and the
first 8 nucleotides annealed to the
template were all ribonucleotides
(Fig. 5). The annealed RNA was
included to prevent possible cleav-
age by Dna2 resulting from its heli-
case activity or transient unanneal-
ing of the annealed portion of the
substrate.
We first determined whether
Dna2 bound to the RNA flap in the
same fashion as shown previously
for a DNA flap (Fig. 1A). Fig. 5A
shows the results of the gel shift
assay used to determine binding.
The RNA flap substrate shifted to a
higher molecular weight complex
upon addition of Dna2, indicating
binding. The amount of shifted
product increased with the amount
of Dna2 added. At 200 fmol of Dna2
over 90% of the substrate was
shifted into aDna2-dependent band
(Fig. 5A, lane 3). We then deter-
mined FEN1 cleavage over time
with and without pre-bound Dna2
FIGURE 4. FEN1 removes Dna2 from the flap substrate. Dna2 (200 fmol)
was pre-bound to 5 fmol of labeled substrate; 10 (lane 7), 25 (lane 8), and 50
fmol (lane 9) of FEN1was then added followedby the addition of streptavidin
as described under “Experimental Procedures.” Lanes 3–5 indicate binding of
FEN1 alone at the same concentrations as in lanes 7–9, respectively. Lane 6 is
a control of pre-bound Dna2 (200 fmol) without FEN1 addition. Lane 1 is the
substrate alone, and lane 2 the substrate plus streptavidin. The substrate is
depicted above the gel, the asterisk indicates the site of the 3 32P radiolabel,
and B indicates the 5-biotin.WT, wild type.
FIGURE 5. Wild type (WT) Dna2 does not inhibit FEN1 cleavage on an RNA flap. A, binding of Dna2 was
assessed on a 30-nucleotide RNA flap substrate as described under “Experimental Procedures.” Dna2 was
bound at 100 fmol (lane 2) and 200 fmol (lane 3). Lane 1 is the substrate alone control. Percent bound, shown
below the gel, is defined as: (bound/(bound  unbound))  100. B, 5 fmol of the 30-nucleotide RNA flap
substrate was incubated under the following conditions (described under “Experimental Procedures”): circles,
5 fmol of FEN1was added at time zero; squares, 200 fmol of Dna2 E675Awas pre-boundwith substrate prior to
FEN1 addition at time zero. Time points were taken at 0, 0.25, 0.5, 1, 2.5, 5, and 10 min. Percent cleavage is
defined as: (cleaved/(cleaved uncleaved)) 100. The graph is an average of two experiments, and error bars
indicate S.D. The substrate, used in both A and B, is depicted above A, where RNA is labeled in gray, DNA is
labeled in black, and the asterisk indicates the site of the 3 32P radiolabel.
FEN1 Disengages Dna2
DECEMBER 15, 2006•VOLUME 281•NUMBER 50 JOURNAL OF BIOLOGICAL CHEMISTRY 38569
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 26, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
(Fig. 5B). As expected, the presence of bound Dna2 did not
produce a significant change in the cleavage rate. In fact, these
two curves match up almost identically (Fig. 5B, circles and
squares). This demonstrates that the wild type Dna2, just as the
Dna2 E675A, allows access of FEN1 to its cleavage site.
Dna2 Binds to Blocked Flap Substrates in a Non-tracking
Mode—Dna2 cleavage activity is prevented when the 5 end of
the flap is blocked (30). In view of this, we tested whether Dna2
could still bind a blocked flap. In Fig. 6, the substrate was
blocked with streptavidin prior to the addition of Dna2 to the
reaction. Dna2 was then added in increasing amounts. A gel
shift assay was then performed to assess binding. Dna2 was
found to bind even though the flaps were blocked (Fig. 6, lanes
2 and 3). It was then verified that Dna2 cleavage was still inhib-
ited on streptavidin blocked flaps by denaturing PAGE (data
not shown). This shows that Dna2 requires tracking for nucle-
ase activity but can bind, in a non-tracking fashion, even when
the flap is blocked at the 5 end. This observation is consistent
with previous reports that Dna2 is active, at low levels, as a
helicase on circular and primer-blocked substrates (23, 25).
When Dna2 is bound to an unblocked flap, some fraction may
be bound in the non-tracking mode. FEN1 was able to dissoci-
ate both types of bound Dna2 from the flap, as cleavage
remained greater than 90% on Dna2-blocked flaps (see Figs. 1B
and 5B).
DISCUSSION
In this report, we have shown that a nuclease-inactive Dna2
could bind a 53-nucleotide DNA flap substrate almost quanti-
tatively, but its presence did not inhibit FEN1 cleavage. Further
analysis showed that the Dna2 did not allow FEN1 to bypass its
tracking requirement. Instead, the Dna2 was observed to disso-
ciate from the substrate. Use of an RNA flap substrate allowed
the same type of experiment to be performed with wild type
Dna2, which cannot cleave RNA. Again, FEN1 was active on an
RNA flap substrate bound by wild type Dna2.
FEN1 and Dna2 have been shown to interact both physically
and genetically, but the direct role of Dna2 in OFP still remains
uncertain (15). Results from reconstituted systems suggest that
mainly short flaps arise during lagging strand replication and
that only FEN1 would be required to cleave such flaps (5,
34–36). FEN1 is envisioned to cut repeatedly into the RNA and
into the DNA primer as the flap is displaced. Once cleavage
occurs in the DNA, the FEN1 product forms a nicked substrate
for the joining reaction. Dna2 has been proposed to be required
for flaps that escape FEN1 cleavage and become long enough to
be coated by RPA (9, 23). The RPA inhibits FEN1 but stimulates
Dna2 (14, 28). Dna2 can slide onto long flaps, moving beyond
the RNA into theDNA (23, 28). There it cleaves tomake a short
flap, which RPA cannot bind. This short flap is then a good
substrate for FEN1 (5, 14).
The interaction of FEN1 with a flap already bound by Dna2
had not been addressed previously. Surprisingly, we found that
FEN1 acts to remove the Dna2 bound to the flap (Fig. 4). This
removal is so efficient that cleavage rates are comparable to
those without Dna2 present (Figs. 1 and 5). This is the first
evidence that the physical interaction of the two proteins is
relevant for OFP.
Dna2 is unable to cleave a flap blocked at the 5 end with
biotin-streptavidin (30, 37). In addition, Dna2 is unable to
cleave past a bound primer or a branch point of a modified flap
(30). In this manner the Dna2 behaves like a ring threaded over
the end of the flap. Although the mechanism of Dna2 removal
has not been elucidated here, our current knowledge of the two
proteins allows some informed speculation. When both Dna2
and FEN1 are present, our results show that binding of FEN1 to
the substrate at the expense of Dna2 must be highly favored,
energetically. FEN1 is not a helicase or even anATPase. It is not
known whether FEN1 binds the substrate with higher affin-
ity than Dna2. Although further binding studies of both
FEN1 and Dna2 are required, a reasonable hypothesis is that
the binding energy of FEN1 to a complex of Dna2 and sub-
strate induces a conformational change that results in Dna2
dissociation. Although this proposal is consistent with
experimental data, crystallographic studies are needed to
verify the exact structural features accounting for the
threading behavior and disengagement.
Because FEN1 is also obligated to track from the 5 end of the
flap to the flap base for cleavage, it is not surprising that FEN1 is
inhibited by proteins bound to the flap. Both RPA and E. coli
single-stranded binding protein have been shown to stop FEN1
cleavage (13). Also FEN1 activity is stopped by primers
annealed to the flap and by a biotin-streptavidin block at the 5
FIGURE 6. Dna2 binds to blocked flap substrates. 5 fmol of the 53-nucleo-
tide substratewas incubatedwith 250 fmol of streptavidin for 10min at 37 °C.
Dna2was thenadded to the reactionat 100 fmol (lane 2) and200 fmol (lane 3),
followed by incubated at 37 °C for 10 min. Reactions were then run by gel
shift, as described under “Experimental Procedures,” to assess Dna2 binding.
Lane 1 is the substrate plus streptavidin control. The substrate is depicted
above the gel, the asterisk indicates the site of the 3 32P radiolabel, and B
indicates the 5-biotin.
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end (13). As with these proteins and primers, bound Dna2,
approximately three times the size of FEN1, was expected to
block the smaller nuclease. The facile ability of FEN1 to bypass
Dna2 implies that a removal mechanism has evolved between
the two proteins.
The FEN1-Dna2 disengagement mechanism may be func-
tionally similar to the interaction between Dna2 and RPA.
Although Dna2 cleavage on the flap is also blocked by primers,
streptavidin, and single-stranded binding protein, it is not
inhibited, but rather is stimulated, by the presence of RPA (28,
30). It is not known whether motion of Dna2 disengages the
RPA. Because this phenomenon is an important element of the
proposed RPA/Dna2/FEN1 pathway of long-flap removal, it
deserves additional investigation. Both of these special protein-
protein interactions support the role of Dna2 in OFP.
We have shown that if Dna2 is bound to a flap and cannot
cleave, it is disengaged by FEN1. Why might this disengage-
ment be necessary in vivo? Although Dna2 is a helicase and
endonuclease, it has different properties from most enzymes
with these activities (30). Helicases generally bind to any single-
stranded region large enough to accommodate binding before
beginning ATP-dependent tracking (38, 39). Similarly, endo-
nucleases generally bind and cleave directly at their cleavage
sites. It has been speculated that both FEN1 and Dna2 have
evolved their tracking mechanisms to protect the single-
stranded regions of template between Okazaki fragments from
endonucleolytic cleavage (30, 40). Because Dna2 and FEN1 are
both abundant, soluble proteins, they should compete for newly
created flaps. FEN1 has been proposed to cleave most flaps
without the aid of Dna2 (5, 34–36). It is possible that the dis-
engagement mechanism ensures that FEN1 enters first, unless
the flaps become long enough to be coated by RPA.
Another possible reason is that Dna2 disengagement allows
FEN1 to be the dominant nuclease during displacement of the
RNA portion of the flap. If Dna2 threads onto a flap ahead of
FEN1 while the base of the flap is still only RNA, Dna2 would
block FEN1 cleavage. This is likely because Dna2 binding to
ssRNA is reported to be slightly greater or at least equal to that
of ssDNA (23). The capacity for disengagement would allow
FEN1 to cleave within the RNA, instead of having to wait for
further displacement to drive Dna2 into the DNA. Also Dna2 is
not effective as a nuclease at the very base of a flap (14, 23). If it
were threaded onto the flap ahead of the FEN1, it would have to
wait until five or more nucleotides of DNA had been displaced
before it could make a cut. The FEN1 could be active through-
out this process of RNAandDNA removal if it easily disengages
any Dna2 that precedes it.
Another possibility is that Dna2 does not readily dissociate
from the DNA after it makes a cut in the long-flap pathway. In
the cell the helicase activity would constantly be driving Dna2
toward the base of the flap. Because it does not cleave close to
the base, it would always have a short segment of the flap on
which to bind. If FEN1 were unable to access this short flap
because Dna2 remains bound (see Fig. 2), the ligatable product
would not be formed unless FEN1 had a way to promote Dna2
dissociation. Frequent failure to generate a ligatable nick would
be dangerous, because unprocessed Okazaki fragments are
potential recombination intermediates that can lead to repeat
sequence expansion and genome instability (2, 9, 35, 41, 42).
We showed that Dna2 binds unblocked flaps in a tracking
mode that allows cleavage (30). It also binds blocked flaps in a
non-trackingmode that does not allow cleavage. Some fraction
of the Dna2 bound to an unblocked flap may be in the non-
trackingmode. FEN1 has the ability to dissociate both from the
flaps (see Fig. 4). Dna2 binding in the non-trackingmodewould
cause potential problems in vivo if not removed by FEN1. If
Dna2 were to remain bound, it would block FEN1 cleavage.
Removal of Dna2 bound in the non-tracking mode is another
reason why FEN1 had to evolve a Dna2 dissociation mecha-
nism. RPAmay also play a role in regulating the binding modes
of Dna2. Further studies will help to uncover the mechanism
and regulation of Dna2 binding in both the tracking and non-
tracking modes.
Although our results show that FEN1 causes the dissociation
of Dna2, they do not definitively prove that Dna2 must dissoci-
ate prior to cleavage by FEN1. Recalling that FEN1 and Dna2
interact (15), it is formally possible that a complex can form
between the proteins that allow FEN1 to cleave past a Dna2
bound on the flap. Although an unlikely scenario, this would
mean that FEN1 could slide down the flap, interact with Dna2
in a way that allows FEN1 cleavage, and then induce the disso-
ciation of Dna2.
It has been proposed previously that RPA stimulation of
Dna2 and inhibition of FEN1 orders the reactions of the two
nucleases on long flaps (28). Here we propose that the inability
of Dna2 to block FEN1 cleavage also properly orders their reac-
tions on short flaps. This allows FEN1 to cleave in an unob-
structed manner on RNA flaps and allows the completion of
flap removal by FEN1 to produce the nick for ligation. Because
Dna2 and FEN1 interact, removal of Dna2 may position FEN1
to carry out RNAorDNA flap cleavagemore efficiently.Overall
our results support a role for Dna2 in processing at least some
fraction of Okazaki fragments. They also suggest that the inter-
play of Dna2, RPA, and FEN1 is even more tightly orchestrated
than previously believed.
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